ALPHAEON Corporation provides beauty, wellness, and lifestyle products in the United States. It offers age defense creams for dry, normal, and combination skin; and revitalizing concentrate serums, face and eyes cleansing solutions, skin radiance smoothing creams, and deep repair soothing balms. The company offers skin care assessment solutions; credit cards that provide financing options for individuals; and PRN (Physician Recommended Nutriceuticals) products, which include omega-3 EPA and vitamin D3 soft-gels; omega-3 EPA and vitamin D3 liquids; macular vitamins; and custom-formulated omega-3 EPA, vitamin D3, and carotenoids soft-gels for dry eyes. It also helps patients to find physicians...
18191 Von Karman Avenue
Irvine, CA 92612
Founded in 2012
ALPHAEON Corporation Appoints Jeff Castillo as President of the Americas, and Kuntal Joshi as President of Asia Pacific
Jan 28 15
ALPHAEON Corporation announced that Jeff Castillo has joined the organization as President of the Americas, and Kuntal Joshi has joined as President of Asia Pacific. Mr. Castillo and Mr. Joshi each bring more than 25 years of experience in the medical device sector to their roles at the company. Mr. Castillo was most recently a Divisional Vice President at Abbott Medical Optics (AMO) where he focused on leading the Americas organization to double-digit growth through greater alignment and focus on customer needs and market dynamics. While at AMO, Jeff was responsible for deploying a customer focused strategy concentrating on strengthening AMO's value proposition through the creation of new services, launching value added products, and maximizing the portfolio. Prior to AMO, Mr. Castillo spent 22 years at Johnson & Johnson, where he held a variety of senior commercial positions based in the U.S. and Latin America. Prior to joining ALPHAEON, Mr. Joshi spent the last 12 years in the Asia Pacific Region.
FDA Accepts Investigational New Drug Application for ALPHAEON's Neurotoxin EVOSYAL
Sep 4 14
ALPHAEON(R) Corporation, subsidiary of Strathspey Crown Holdings LLC, announced that the U.S. Food and Drug Administration (FDA) accepted the Investigational New Drug (IND) application to conduct clinical studies for EVOSYAL(TM), an advanced Botulinum toxin Type A neurotoxin that was acquired by ALPHAEON last October, as part of the acquisition of Evolus Inc. According to the ASPS(R), Botulinum toxin Type A was injected for cosmetic purposes more than 6 million times last year, accounting for over 2 billion dollars of consumer spend annually, which was a 3% increase from the previous year. ALPHAEON expects the initial clinical trial to be fully enrolled by the end of 2014.
ALPHAEON Corporation Announces Executive Changes
May 13 14
ALPHAEON Corporation named a team of leaders in healthcare and business to its board of directors. The company's directors include the following industry leaders: Robert E. Grant, chief executive officer of the company, presently serves as chairman and managing partner of Strathspey Crown Holdings, LLC, company's parent company. For more than 20 years, he has played a pivotal role in successful technology and business development in the pharmaceutical, medical device and healthcare markets. Most recently, he was CEO and president of Bausch + Lomb Surgical and also previously served as president of Allergan Medical, a division of Allergan Inc. Robert Hayman, founder & former chairman and chief executive officer of Discus Dental Inc. Hans Keirstead, Ph.D., is an internationally known stem cell expert that has worked on stem cell-based therapies for late stage cancers, motor neuron diseases, spinal cord injury and retinal diseases. He has served as Founder, President and CEO of Ability Biomedical, where he led the development of an immunotherapy, which he sold to Bristol Myers Squibb, and later California Stem Cell Inc., which was acquired by NeoStem in May 2014. He currently serves as president of NeoStem Oncology. He founded the Sue and Bill Gross Stem Cell Research Center and served as Full Professor of Anatomy and Neurobiology. Richard L. Lindstrom, M.D., is founder and attending surgeon of Minnesota Eye Consultants and Adjunct Clinical Professor Emeritus at the University of Minnesota's Department of Ophthalmology; Associate Director of the Minnesota Lions Eye Bank and Visiting Professor at the University of California Irvine's Gavin Herbert Eye Institute. Dr. Lindstrom currently serves on the Board of Directors of AcuFocus Inc., TLC Vision, TearLab, Refractec, Wavetec, Encore, RevitalVision, and the University of Minnesota Foundation. Vikram Malik is a managing partner in the growth equity firm Strathspey Crown Holdings LLC, company's parent company. During a 26-year career on Wall Street, Mr. Malik recently served as vice chairman of Investment Banking and Global Head of Medical Technology at Deutsche Bank. Patrick Maxwell, M.D., is a clinical professor of plastic surgery at California's Loma Linda University and Vanderbilt University in Nashville. Dr. Maxwell, who also maintains a private practice, Maxwell Aesthetics, has published more than 140 scientific articles, holds 16 U.S. patents for medical devices and co-founded Precision Light recently acquired by Allergan, and is a founder, principle in GID (an adipose/adipose-derived stem cell company). He also designed the Natrelle(R) silicone gel collection of breast implants for Allergan Inc., and founded and chairs the Allergan Academy. Valerie Taupin is founder, chief executive officer and chairman of TEOXANE Laboratories. Joseph Whitters, C.P.A. is a seasoned director and corporate advisor. He currently serves on the board of directors of publicly traded PRGX Global Inc. and InfuSystems Holdings Inc. Chris Cox, a former 17-year member of the U.S. House of Representatives, is a partner in the international law firm Bingham McCutchen LLP and president of Bingham Consulting LLC. He advises global companies on strategic issues, corporate governance, securities regulation and general business. Mr. Cox served as the 28(th) chairman of the Securities and Exchange Commission and chairman of the Homeland Security Committee in the house. Previously, he served as White House counsel to President Ronald Reagan and as corporate partner at Latham & Watkins.